111 related articles for article (PubMed ID: 32524552)
1. CRISPR/Cas9-mediated Generation of Human Endothelial Cell Knockout Models of CCM Disease.
Schwefel K; Spiegler S; Much CD; Felbor U; Rath M
Methods Mol Biol; 2020; 2152():169-177. PubMed ID: 32524552
[TBL] [Abstract][Full Text] [Related]
2. Precise CCM1 gene correction and inactivation in patient-derived endothelial cells: Modeling Knudson's two-hit hypothesis in vitro.
Spiegler S; Rath M; Much CD; Sendtner BS; Felbor U
Mol Genet Genomic Med; 2019 Jul; 7(7):e00755. PubMed ID: 31124307
[TBL] [Abstract][Full Text] [Related]
3. Biallelic CCM3 mutations cause a clonogenic survival advantage and endothelial cell stiffening.
Schwefel K; Spiegler S; Ameling S; Much CD; Pilz RA; Otto O; Völker U; Felbor U; Rath M
J Cell Mol Med; 2019 Mar; 23(3):1771-1783. PubMed ID: 30549232
[TBL] [Abstract][Full Text] [Related]
4. Mural Cell-Specific Deletion of Cerebral Cavernous Malformation 3 in the Brain Induces Cerebral Cavernous Malformations.
Wang K; Zhang H; He Y; Jiang Q; Tanaka Y; Park IH; Pober JS; Min W; Zhou HJ
Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2171-2186. PubMed ID: 32640906
[TBL] [Abstract][Full Text] [Related]
5. Endothelial Differentiation of
Pilz RA; Skowronek D; Mellinger L; Bekeschus S; Felbor U; Rath M
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835400
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of Cerebral Cavernous Malformation Genes Results in Accumulation of von Willebrand Factor and Redistribution of Weibel-Palade Bodies in Endothelial Cells.
Much CD; Sendtner BS; Schwefel K; Freund E; Bekeschus S; Otto O; Pagenstecher A; Felbor U; Rath M; Spiegler S
Front Mol Biosci; 2021; 8():622547. PubMed ID: 34307446
[TBL] [Abstract][Full Text] [Related]
7. Low fluid shear stress conditions contribute to activation of cerebral cavernous malformation signalling pathways.
Li J; Zhao Y; Coleman P; Chen J; Ting KK; Choi JP; Zheng X; Vadas MA; Gamble JR
Biochim Biophys Acta Mol Basis Dis; 2019 Nov; 1865(11):165519. PubMed ID: 31369819
[TBL] [Abstract][Full Text] [Related]
8. Generation and Analysis of CCM Phenotypes in C. elegans.
Popiel E; Derry WB
Methods Mol Biol; 2020; 2152():191-205. PubMed ID: 32524554
[TBL] [Abstract][Full Text] [Related]
9. Differential angiogenesis function of CCM2 and CCM3 in cerebral cavernous malformations.
Zhu Y; Wu Q; Xu JF; Miller D; Sandalcioglu IE; Zhang JM; Sure U
Neurosurg Focus; 2010 Sep; 29(3):E1. PubMed ID: 20809750
[TBL] [Abstract][Full Text] [Related]
10. From Genes and Mechanisms to Molecular-Targeted Therapies: The Long Climb to the Cure of Cerebral Cavernous Malformation (CCM) Disease.
Retta SF; Perrelli A; Trabalzini L; Finetti F
Methods Mol Biol; 2020; 2152():3-25. PubMed ID: 32524540
[TBL] [Abstract][Full Text] [Related]
11. Optical Control of a CRISPR/Cas9 System for Gene Editing by Using Photolabile crRNA.
Zhang Y; Ling X; Su X; Zhang S; Wang J; Zhang P; Feng W; Zhu YY; Liu T; Tang X
Angew Chem Int Ed Engl; 2020 Nov; 59(47):20895-20899. PubMed ID: 33448579
[TBL] [Abstract][Full Text] [Related]
12. Generation of CCM Phenotype by a Human Microvascular Endothelial Model.
Delle Monache S; Retta SF
Methods Mol Biol; 2020; 2152():131-137. PubMed ID: 32524549
[TBL] [Abstract][Full Text] [Related]
13. CCM3 and cerebral cavernous malformation disease.
Wang K; Zhou HJ; Wang M
Stroke Vasc Neurol; 2019 Jul; 4(2):67-70. PubMed ID: 31338212
[TBL] [Abstract][Full Text] [Related]
14. Genomic causes of multiple cerebral cavernous malformations in a Japanese population.
Tsutsumi S; Ogino I; Miyajima M; Ikeda T; Shindo N; Yasumoto Y; Ito M; Arai H
J Clin Neurosci; 2013 May; 20(5):667-9. PubMed ID: 23485406
[TBL] [Abstract][Full Text] [Related]
15. Generation of Cerebral Cavernous Malformation in Neonatal Mouse Models Using Inducible Cre-LoxP Strategy.
Choi JP; Zheng X
Methods Mol Biol; 2020; 2152():253-258. PubMed ID: 32524557
[TBL] [Abstract][Full Text] [Related]
16. Recent insights into cerebral cavernous malformations: the molecular genetics of CCM.
Riant F; Bergametti F; Ayrignac X; Boulday G; Tournier-Lasserve E
FEBS J; 2010 Mar; 277(5):1070-5. PubMed ID: 20096038
[TBL] [Abstract][Full Text] [Related]
17. Postzygotic mosaicism in cerebral cavernous malformation.
Rath M; Pagenstecher A; Hoischen A; Felbor U
J Med Genet; 2020 Mar; 57(3):212-216. PubMed ID: 31446422
[TBL] [Abstract][Full Text] [Related]
18. Contact-dependent signaling triggers tumor-like proliferation of CCM3 knockout endothelial cells in co-culture with wild-type cells.
Rath M; Schwefel K; Malinverno M; Skowronek D; Leopoldi A; Pilz RA; Biedenweg D; Bekeschus S; Penninger JM; Dejana E; Felbor U
Cell Mol Life Sci; 2022 Jun; 79(6):340. PubMed ID: 35661927
[TBL] [Abstract][Full Text] [Related]
19. Novel CCM1, CCM2, and CCM3 mutations in patients with cerebral cavernous malformations: in-frame deletion in CCM2 prevents formation of a CCM1/CCM2/CCM3 protein complex.
Stahl S; Gaetzner S; Voss K; Brackertz B; Schleider E; Sürücü O; Kunze E; Netzer C; Korenke C; Finckh U; Habek M; Poljakovic Z; Elbracht M; Rudnik-Schöneborn S; Bertalanffy H; Sure U; Felbor U
Hum Mutat; 2008 May; 29(5):709-17. PubMed ID: 18300272
[TBL] [Abstract][Full Text] [Related]
20. Production of KRIT1-knockout and KRIT1-knockin Mouse Embryonic Fibroblasts as Cellular Models of CCM Disease.
Goitre L; Fornelli C; Zotta A; Perrelli A; Retta SF
Methods Mol Biol; 2020; 2152():151-167. PubMed ID: 32524551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
